KEEP UP WITH THE LATEST IN INDUSTRY NEWS!
From news about new medicines, pharmacy business insights, and the pharmaceutical industry in general—this is your source!
DrugTopics articles
- SSRIs Are Most Effective in Treatment of Skin-Picking Disorder May 19, 2025Researchers conduct a scoping review to update and determine what the best available options are for treating patients with skin-picking disorder.
- Strategies for Independent Pharmacies to Harness Consumer Trends and Meet the Competition May 19, 2025Pharmacies face mounting challenges amid increased competition, rising operational costs, and complex reimbursement models.
- Children With Skin Diseases Are at Higher Risk of Sleep Disorders May 19, 2025In children aged 5 to 17 with skin disorders, researchers explore the risk of developing psychosocial comorbidities, sleep disturbances, and common related symptoms.
- GLP-1 Usage Does Not Increased Risk of Psychiatric Events, Study Finds May 19, 2025Glucagon-like peptide-1 receptor agonists have been associated with improvements in quality of life (QOL), restrained eating, and emotional eating behavior.
- Q&A: Myths, Misinformation Surrounding Hepatitis Vaccines May 19, 2025Jeff Goad, PharmD, MPH, discusses hesitancy for hepatitis vaccines and the necessary advice pharmacists can utilize to help patients manage these misconceptions.
- FDA Approves Nuvaxovid for the Prevention of COVID-19 May 19, 2025Novavax’s COVID-19 vaccine has been available in the US under emergency use authorization since July 2022.
- Suicide Risk Management Crucial in Dermatological Care May 18, 2025Researchers conducted a clinical review detailing the intersection of dermatology and suicide, explaining why skin conditions lead to increased risk of poor mental health.
- Average Duration of ADHD Medication Is 3 Years for Children, Adolescents May 17, 2025Investigators note that the long-term effects of attention deficit/hyperactivity disorder (ADHD) medication for children remain lacking.
- Rite Aid to Sell Pharmacy Assets From Over 1,000 Stores to CVS, Walgreens May 16, 2025The announcement comes shortly after the company announced it had filed its second chapter 11 bankruptcy in under 2 years.
- Deciphering the Increase in Direct-to-Consumer Drug Advertising May 16, 2025Drug Market experts joined Drug Topics to discuss the rise in direct-to-consumer drug advertising and what it means for patients around the world.
Pharmacy Times articles
- Study Reveals Safety and Effectiveness of RSV Vaccine for Older Adults May 19, 2025New research highlights the effectiveness and safety of RSV vaccines for older adults, revealing critical insights into vaccination benefits and risks.
- Insights from a Pharmacy Times Peer Exchange: Real-World Outcomes and Supportive Care May 19, 2025Pharmacists compare real-world practice data with clinical trial results and discuss supportive care options for patients.
- First Nationwide Seroprevalence Study of HDV in the US Offers Prevalence of HDV Among HBsAg-Positive Specimens May 19, 2025The authors believe the results may serve as a foundation for hepatitis D virus (HDV) testing among hepatitis B virus surface antigen (HBsAg)-positive specimens.
- FDA Approved Antihemophilic factor, PEGylated-Aucl For Pediatric Patients With Hemophilia A May 19, 2025The approval expands the therapy’s indication to children as young as 7 years of age.
- Anti-PD-1 Monoclonal Antibody With Standard of Care Improves Outcomes for BCG-Naïve Bladder Cancer May 19, 2025A study reveals sasanlimab enhances event-free survival in high-risk bladder cancer patients, offering new hope against disease recurrence.
- HPV Vaccine: Balancing Benefits, Risks, and Public Perception May 19, 2025Pharmacists should continue to emphasize the vaccine’s effectiveness in preventing cancer and be prepared to address patient safety concerns.
- Navigating the Impacts of “COVID Brain”: A Pharmacy Student’s Journey May 19, 2025COVID-19 can reshape one’s academic journey and outlook on life.
- FDA Grants Market Clearance to Diagnostic Blood Test for Alzheimer Disease May 19, 2025The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
- FDA Approves Novavax COVID-19 Vaccine for Patients 65 Years and Older, Those With Underlying Conditions May 19, 2025The vaccine, indicated with a restriction on use for those younger than 65 years and without comorbidities, was proven safe and effective in a series of large clinical trials, and marks the first protein-based vaccine to be approved in the United States.
- Know the ABCs of Diabetic Skin Care May 19, 2025Patients should understand that routine skin care is an important facet in the overall management of diabetes.
Helping You Navigate the Returns Process!
Pedigree Statement
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with it’s clients…
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with its clients. This is to ensure that the reverse distribution portion of the supply chain that we service keeps its functionality and integrity for our customers and the public.
Several pedigree and distribution level issues have been raised in the industry. Discounted, indigent-pricing, short dated, bulk purchase, secondary distribution, or DSCSA non-compliant sales could affect the credit available for a product based on a manufacturers determination. We ask that you do not return these products for credit as they are not eligible in most cases. Flash Returns LLC may choose to dispose of these on the pharmacies behalf at no charge if the cost is low relative to the return. Most customers purchasing products from reputable wholesalers will not encounter these issues, however all pharmacies are asked to acknowledge our policy on pedigree and legitimacy of product here and by signing the PSA before a return is initiated.
Some manufacturers may require proof the price paid for a product and what wholesaler distributed the product. Issues causing triggering this could be: bulk or large quantities of single items or lots, or products purchased speculatively. In some cases we may request invoices from the customer to ensure Flash Returns or manufacturer policy is being met. If none are available or if the information isn’t accepted by the manufacturer it could cause the return to be non-returnable.
Flash Returns, LLC cannot guarantee or be liable for the value or credit for products that were purchased outside of manufacturer accepted distribution channels. This could include products: purchased from a wholesaler that is not an approved vendor, products not purchased directly from a particular manufacturer, purchased on a speculative basis, diverted or counterfeit products, foreign products, and any product purchased on a non-returnable basis, including short-dated product purchased at discounted pricing.
At any time, Flash Returns, LLC or a manufacturer may require invoices or pedigree information demonstrating proof of purchase. If product has been shipped by Flash Returns, LLC or the Customer to a manufacturer or their agent, Flash Returns, LLC cannot guarantee or facilitate the return of product to the Customer. Manufacturers reverse the right to destroy product they deem not credit worthy or suspect. Manufacturers agreeing to return product to customers will do so at the customers expense. Flash Returns, LLC shall not be responsible for reimbursing a Customer for such product.
If Customer is unable to have product returned within 21 days, product is subject to be destroyed without any payment or credit issued to Customer. In any dispute, failure by Customer to provide invoices for a product or pedigree if requested shall release Flash Returns, LLC from any and all liability of products involved in dispute including the full value of the product. More information on drug pedigrees is available on the FDA website at:
Pedigree Statement
P: 833.553.5274
E: SignUp@FlashReturns.com